Cytology Versus High-Risk HPV Testing for Follow-up of HPV-Positive Women Without CIN

Screening for cervical cancer is often considered the success story for cancer screening in the United States. However, much room for improvement still exists. For example, experts have yet to establish the best follow-up strategy for women with an abnormal Papanicolaou test and high-risk human papillomavirus (HPV) followed by a normal colposcopy or biopsy that is negative for cervical intraepithelial neoplasia. The incorporation of HPV testing has allowed the development of a more sensitive and cost-efficient strategy. This article presents a brief overview of related guidelines and current modalities, and reviews selected studies. Finally, future directions and a possible schema for clinical management of these patients are included.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Kristopher J. Kimball, MD, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, 618 South 19th Street, OHB 538, Birmingham, Alabama 35249. E-mail: kimballkj@gmail.com
  • 1.

    Cervical Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2005:161.

  • 2.

    FleurenceRLDixonJMMilanovaTF. Review of the economic and quality-of-life burden of cervical human papillomavirus disease. Am J Obstet Gynecol2007;196:206212.

    • Search Google Scholar
    • Export Citation
  • 3.

    ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol2003;188:13831392.

    • Search Google Scholar
    • Export Citation
  • 4.

    GuidoRSchiffmanMSolomonD. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol2003;188:14011405.

    • Search Google Scholar
    • Export Citation
  • 5.

    PartridgeEEAbu-RustumNCamposS. The NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer Screening version 12008. Available at: http://www.nccn.org/professionals/physician_gls/PDF/cervical_screening.pdf. Accessed October 8 2007.

    • Search Google Scholar
    • Export Citation
  • 6.

    WrightTCJrCoxJTMassadLS. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. J Low Genit Tract Dis2002;6:127143.

    • Search Google Scholar
    • Export Citation
  • 7.

    CuzickJClavelCPetryKU. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer2006;119:10951101.

    • Search Google Scholar
    • Export Citation
  • 8.

    NandaKMcCroryDCMyersER. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med2000;132:810819.

    • Search Google Scholar
    • Export Citation
  • 9.

    WrightTCJr. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?Clin Obstet Gynecol2007;50:313323.

  • 10.

    DaveyEBarrattAIrwigI. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet2006;367:122132.

    • Search Google Scholar
    • Export Citation
  • 11.

    TaylorSKuhnLDupreeW. Direct comparison of liquid-based and conventional cytology in a South African screening trial. Int J Cancer2006;118:957962.

    • Search Google Scholar
    • Export Citation
  • 12.

    NobbenhuisMAWalboomersJMHelmerhorstTJ. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet1999;354:2025.

    • Search Google Scholar
    • Export Citation
  • 13.

    WalboomersJMJacobsMVManosMM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol1999;189:1219.

    • Search Google Scholar
    • Export Citation
  • 14.

    PretoriusRGPetersonPAziziF. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol2006;195:12601265.

    • Search Google Scholar
    • Export Citation
  • 15.

    WrightTCJrSchiffmanMSolomonD. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol2004;103:304309.

    • Search Google Scholar
    • Export Citation
  • 16.

    HoGYBiermanRBeardsleyL. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med1998;338:423428.

  • 17.

    BrownDRShewMLQadadriB. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis2005;191:182192.

    • Search Google Scholar
    • Export Citation
  • 18.

    KulasingamSLHughesJPKiviatNB. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA2002;288:17491757.

    • Search Google Scholar
    • Export Citation
  • 19.

    ASCUS-LSIL Triage Study (ALTS) Group.A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol2003;188:13931400.

    • Search Google Scholar
    • Export Citation
  • 20.

    CoxJTSchiffmanMSolomonD. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol2003;188:14061412.

    • Search Google Scholar
    • Export Citation
  • 21.

    IsmailSMColcloughABDinnenJS. Reporting cervical intra-epithelial neoplasia (CIN): intra- and interpathologist variation and factors associated with disagreement. Histopathology1990;16:371376.

    • Search Google Scholar
    • Export Citation
  • 22.

    KhanMJCastlePELorinczAT. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst2005;97:10721079.

    • Search Google Scholar
    • Export Citation
  • 23.

    SaraiyaMIrwinKLCarlinL. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer2007;110:10241032.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 76 68 0
PDF Downloads 8 8 0
EPUB Downloads 0 0 0